NCT07069439View on ClinicalTrials.gov

Turkish Version of the Parent-Reported Drug Hypersensitivity Quality of Life Questionnaire

Enrolling by invitationOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

October 30, 2025

Study Completion Date

October 30, 2025

Conditions
Drug HypersensitivityQuality of Life (QOL)CaregiversAllergy and Immunology
Interventions
BEHAVIORAL

Turkish Version of the P-DrHy-Q

Participants will complete the Turkish-translated version of the Parent-reported Drug Hypersensitivity Quality of Life Questionnaire (P-DrHy-Q), which includes 12 items assessing psychosocial burden in two domains: mental health and social activity. A subgroup of participants (n ≈ 20) will complete the same questionnaire again after 14 days to assess test-retest reliability

Trial Locations (1)

Unknown

Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization, Istanbul

All Listed Sponsors
lead

Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization

OTHER

NCT07069439 - Turkish Version of the Parent-Reported Drug Hypersensitivity Quality of Life Questionnaire | Biotech Hunter | Biotech Hunter